FDA — authorised 14 November 2001
- Application: BLA103950
- Marketing authorisation holder: BIOVITRUM AB
- Local brand name: KINERET
- Indication: VIAL — SUBCUTANEOUS
- Status: approved
🇺🇸 Anakinra in United States
FDA authorised Anakinra on 14 November 2001
Marketing authorisations
FDA
- Status: approved
Anakinra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Anakinra approved in United States?
Yes. FDA authorised it on 14 November 2001; FDA has authorised it.
Who is the marketing authorisation holder for Anakinra in United States?
BIOVITRUM AB holds the US marketing authorisation.